ChiCTR2300077360 版本V1.1 版本创建时间2024/05/25 16:46:25 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300077360 

最近更新日期:

Date of Last Refreshed on:

2023-11-06 16:59:24 

注册时间:

Date of Registration:

2023-11-06 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

安徽心力衰竭多中心注册登记研究

Public title:

Multi-center Heart Failure Registration Study in Anhui Province

注册题目简写:

English Acronym:

研究课题的正式科学名称:

安徽心力衰竭多中心注册登记研究

Scientific title:

Multi-center Heart Failure Registration Study in Anhui Province

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈康玉 

研究负责人:

陈康玉 

Applicant:

Kangyu Chen 

Study leader:

Kangyu Chen 

申请注册联系人电话:

Applicant telephone:

+86 180 5600 5099

研究负责人电话:

Study leader's
telephone:

+86 180 5600 5099

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

ahslyycky@126.com

研究负责人电子邮件:

Study leader's E-mail:

ahslyycky@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

安徽省合肥市庐阳区庐江路17号

研究负责人通讯地址:

安徽省合肥市庐阳区庐江路17号

Applicant address:

17 Lujiang Road, Luyang District, Hefei, Anhui

Study leader's address:

17 Lujiang Road, Luyang District, Hefei, Anhui

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

安徽省立医院

Applicant's institution:

Anhui Provincial Hospital

研究负责人所在单位:

安徽省立医院

Affiliation of the Leader:

Anhui Provincial Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023KY伦审第310号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国科学技术大学附属第一医院医学研究伦理委员会

Name of the ethic committee:

Medical Research Ethics Committee of the First Affiliated Hospital of University of Science and Technology of China

伦理委员会批准日期:

Date of approved by ethic committee:

2023-09-24 00:00:00

伦理委员会联系人:

沈佐君

Contact Name of the ethic committee:

Shen Zuojun

伦理委员会联系地址:

安徽省合肥市庐阳区庐江路17号

Contact Address of the ethic committee:

17 Lujiang Road, Luyang District, Hefei, Anhui

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 551 6228 2931

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

安徽省立医院

Primary sponsor:

Anhui Provincial Hospital

研究实施负责(组长)单位地址:

安徽省合肥市庐阳区庐江路17号

Primary sponsor's address:

17 Lujiang Road, Luyang District, Hefei, Anhui

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽省

市(区县):

Country:

China

Province:

Anhui

City:

单位(医院):

安徽省立医院

具体地址:

安徽省合肥市庐阳区庐江路17号

Institution
hospital:

Anhui Provincial Hospital

Address:

17 Lujiang Road, Luyang District, Hefei, Anhui

经费或物资来源:

自筹

Source(s) of funding:

Self funded

研究疾病:

心力衰竭  

Target disease:

Heart Failure

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

本项目通过多中心观察性队列研究,记录心力衰竭患者基线、诊疗和随访数据,掌握安徽地区心力衰竭患者的流行病学特点,评估真实世界中的药物、手术等治疗方式的疗效和安全性,预测患者预后。  

Objectives of Study:

This project through multi-center obserational cohort study, record the baseline and follow-up data, diagnosis and treatment for heart failure patients, grasp the anhui regional epidemiological characteristics of patients with heart failure, to evaluate the treatment such as medicaments, operation in the real world of the efficacy and safety, and predict the prognosis of patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①年龄≥18岁; ②住院诊断为心力衰竭; ③签署知情同意书。

Inclusion criteria

1) Age ≥18 years old; 2) The patient was hospitalized with a diagnosis of heart failure; 3) All subjects gave informed consent to the content of the study and signed the informed consent form.

排除标准:

1) 妊娠或正准备妊娠及哺乳期妇女; 2)依从性差、认知障碍或其他原因不能配合完成研究的患者

Exclusion criteria:

1) Pregnant or preparing to become pregnant and lactating women; 2) Patients with poor compliance, cognitive impairment or other reasons who cannot cooperate in completing the study;

研究实施时间:

Study execute time:

From 2023-10-09 00:00:00 To 2028-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-11-12 00:00:00 To 2028-03-31 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

12000

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

安徽省立医院 

单位级别:

三甲医院 

Institution
hospital:

Anhui Provincial Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

安徽医科大学第二附属医院 

单位级别:

三甲医院 

Institution
hospital:

The Second Affiliated Hospital of Anhui Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

蚌埠医学院第一 附属医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Bengbu Medical College

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

皖南医学院弋矶山医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Wannan Medical College

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

安徽中医药大学第一附属医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Anhui University of Chinese Medicine

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

安徽省第二人民医院 

单位级别:

三级甲等 

Institution
hospital:

Anhui the Second Provincial People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

合肥市第一人民医院 

单位级别:

三级甲等 

Institution
hospital:

Hefei First People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

合肥市第二人民医院 

单位级别:

三级甲等 

Institution
hospital:

Hefei Second People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

芜湖市第二人民医院 

单位级别:

三级甲等 

Institution
hospital:

The Second People's Hospital of Wuhu

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

滁州市第一人民医院 

单位级别:

三级甲等 

Institution
hospital:

Chuzhou First People's Hospitai

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

亳州市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Bozhou People's Hospitai

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

安庆市立医院 

单位级别:

三级甲等 

Institution
hospital:

Anqing Municipal Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

安庆市第一人民医院 

单位级别:

三级甲等 

Institution
hospital:

Anqing FIrst People's Hospitai

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

阜阳市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Fuyang People's Hospitai

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

淮北市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Huaibei People's Hospitai

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

蚌埠市第三人民医院 

单位级别:

三级甲等 

Institution
hospital:

Bengbu Third People‘s Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

德驭医疗马鞍山总医院 

单位级别:

三级甲等 

Institution
hospital:

Ma"anshan Cental Hospital Co., Ltd.

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

铜陵市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Tongling People's Hospitai

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

芜湖市第二人民医院 

单位级别:

三级甲等 

Institution
hospital:

Wuhu Second People's Hospitai

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

宁国市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Ningguo People's Hospitai

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽省 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

明光市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Mingguang People's Hospitai

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

心力衰竭再入院

指标类型:

主要指标

Outcome:

Hospital admission for worsening heart failure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心血管死亡

指标类型:

主要指标

Outcome:

Cardiovascular death

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

全因死亡

指标类型:

次要指标

Outcome:

All-cause mortality

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

急性心肌梗死

指标类型:

次要指标

Outcome:

Acute myocardial infarction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

卒中

指标类型:

次要指标

Outcome:

Stroke

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

NT-proBNP

指标类型:

次要指标

Outcome:

NT-proBNP

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

sST2 水平

指标类型:

次要指标

Outcome:

sST2 level

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

NYHA 分级变化

指标类型:

次要指标

Outcome:

NYHA grading variations

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

KCCQ评分

指标类型:

次要指标

Outcome:

KCCQ score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血红蛋白

指标类型:

次要指标

Outcome:

hemoglobin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血肌酐

指标类型:

次要指标

Outcome:

Serum creatinine

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

左室舒张末期容积

指标类型:

次要指标

Outcome:

Left ventricular end-diastolic volume

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

左室收缩末期容积

指标类型:

次要指标

Outcome:

Left ventricular end systolic volume

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

左房容积

指标类型:

次要指标

Outcome:

Left atrial volume

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

左室射血分数

指标类型:

次要指标

Outcome:

Left ventricular ejection fraction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肺动脉收缩压

指标类型:

次要指标

Outcome:

Pulmonary artery systolic pressure

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心电图参数

指标类型:

次要指标

Outcome:

Ecg parameters

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

磁共振参数

指标类型:

次要指标

Outcome:

Magnetic resonance parameters

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

未使用

Randomization Procedure (please state who generates the random number sequence and by what method):

Not used

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

原始数据申请需提交研究计划书并经本试验管理委员会批准。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Applicants need provide a study proposal which will be approved by the trial steering committee

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

研究的数据将有第三方提供的电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The study data will be captured and managed by an Electronic Data Capture company.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-11-06 16:55:08